Previous Article | Next Article 
Journal of Virology, June 2000, p. 5619-5628, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Versatility of the Accessory C Proteins of Sendai Virus:
Contribution to Virus Assembly as an Additional Role
Mohammad K.
Hasan,1
Atsushi
Kato,1
Miki
Muranaka,2
Ryoji
Yamaguchi,2
Yuko
Sakai,3
Ikuyoshi
Hatano,4
Masato
Tashiro,1 and
Yoshiyuki
Nagai3,5,*
Department of Viral Diseases and Vaccine
Control,1 Department of Safety Research
on Biologics,4 and AIDS Research
Center,5 National Institute of Infectious
Diseases, Tokyo 208-0011, Department of Pathology, Faculty of
Agriculture, Miyazaki University, Miyazaki
889-2155,2 and Department of Viral
Infection, Institute of Medical Science, University of Tokyo, Tokyo
108-8639,3 Japan
Received 29 December 1999/Accepted 23 March 2000
 |
ABSTRACT |
The P/C mRNA of Sendai virus (SeV) encodes a nested set
of accessory proteins, C', C, Y1, and Y2, referred to collectively as C
proteins, using the +1 frame relative to the open reading frame of
phospho (P) protein and initiation codons at different positions. The C
proteins appear to be basically nonstructural proteins as they are
found abundantly in infected cells but greatly underrepresented in the
virions. We previously created a 4C(
) SeV, which expresses none of
the four C proteins, and concluded that the C proteins are
categorically nonessential gene products but greatly contribute to
viral full replication and infectivity (A. Kurotani et al., Genes Cells
3:111-124, 1998). Here, we further characterized the 4C(
) virus
multiplication in cultured cells. The viral protein and mRNA synthesis
was enhanced with the mutant virus relative to the parental wild-type
(WT) SeV. However, the viral yields were greatly reduced. In addition,
the 4C(
) virions appeared to be highly anomalous in size, shape, and
sedimentation profile in a sucrose gradient and exhibited the ratios of
infectivity to hemagglutination units significantly lower than those of
the WT. In the WT infected cells, C proteins appeared to
colocalize almost perfectly with the matrix (M) proteins, pretty well
with an external envelope glycoprotein
(hemagglutinin-neuraminidase [HN]), and very poorly with the internal
P protein. In the absence of C proteins, there was a significant delay
of the incorporation of M protein and both of the envelope proteins, HN
and fusion (F) proteins, into progeny virions. These results strongly
suggest that the accessory and basically nonstructural C proteins are critically required in the SeV assembly process. This role of C
proteins was further found to be independent of their recently discovered function to counteract the antiviral action of
interferon-
/
. SeV C proteins thus appear to be quite versatile.
 |
INTRODUCTION |
Sendai virus (SeV) is an
enveloped virus with a linear, nonsegmented, negative-sense RNA
genome of 15,384 nucleotides. It belongs to the genus
Respirovirus of the family Paramyxoviridae. The
genome encodes, in a 3'-to-5' order, the nucleocapsid (N) protein, phospho (P) protein, matrix (M) protein, fusion (F) protein, hemagglutinin-neuraminidase (HN), and large (L) protein. The genome RNA
is tightly encapsidated with the N protein subunits and is further
complexed to the polymerase comprising the L and P protein subunits
(14). This ribonucleoprotein (RNP) complex represents the internal core structure of the virion. The viral envelope contains
two glycoproteins, HN and F. The former mediates viral attachment to the surface of susceptible cells, and the latter is
required for the fusion of the envelope with the cellular membrane to
introduce the genomic material into the cytoplasm. The envelope lipid
bilayer is derived from the host cell plasma membrane during the final
step of assembly by budding. There is a layer of M proteins between the
envelope and RNP (30). The M protein has been thought to
play a critical role in assembly (29, 34, 45, 46).
There is only a single promoter at the 3' end for the polymerase. By
recognizing the stop (termination/polyadenylation) and restart signals
present at each gene boundary, the polymerase gives rise to each mRNA
(reviewed in reference 23). The gene expression is
usually monocistronic, generating a single mRNA, which directs a single
primary translation product. However, the P gene of
Paramyxovirinae is a notable exception, because it gives rise to multiple protein species by means of overlapping frames and by
a process known as RNA editing, or pseudotemplated insertion of
nucleotide(s) into the transcript at a specific genome locus (reviewed
in references 23, 24, and 26).
In SeV RNA editing, the pseudotemplated addition of one G residue
produces an mRNA that encodes the protein termed V, while the unedited
mRNA that is the exact copy of the P gene encodes P protein. Thus, P
and V proteins are N coterminal, while the
1 frame is used to
generate the C-terminal half of the V protein. By disrupting the
editing locus in a cDNA plasmid generating a full-length copy of SeV
antigenome RNA, we succeeded in recovering a virus that was defective
in G insertion and V protein production. Although categorized as a
nonessential gene product completely dispensable for viral replication
in cells in culture, the V protein was essential for maintaining a high
viral load in mice, the natural host, and producing fatal pneumonia
(17). This luxury function required for pathogenesis has
been primarily mapped to the unique C-terminal half that is cysteine
rich (18).
An open reading frame (ORF) that overlaps the N-terminal portion of the
SeV P ORF in the +1 frame produces a nested set of proteins which are C
coterminal, called C', C, Y1, and Y2, and referred to collectively as
the C proteins (5, 6). Translation of C' is initiated on a
non-AUG codon, ACG at the position 81 of P mRNA, whereas the other
three start on AUGs at positions 114, 183, and 201, respectively
(3, 13). The C-related proteins are expressed from the P
gene of all members of the genera Paramyxovirus and
Morbillivirus but not Rubulavirus. No C protein
exists in the subfamily Pneumovirinae, except for the
pneumonia virus of the mouse, whose P gene contains a C-like ORF and
expresses two C-like proteins (1). The number of C proteins
expressed from these viral P genes varies due to the use of a variable
number of in-phase start codons. There are four from SeV, two or
three from human parainfluenza virus type 1 (hPIV-1), but only one from hPIV-3 and measles virus (MV) P genes (reviewed in reference
23). The C protein sequences are conserved at least
within a genus but are divergent between the genera (reviewed in
reference 26). Commonly, C proteins are relatively
small (180 to 204 amino acids [aa]) and highly basic. Even in a
distantly related rhabdovirus, vesicular stomatitis virus (VSV), a
C-like ORF overlapping the P ORF is present, and two C proteins are
expressed from this frame (38).
The C protein is regarded as the major species of SeV C-related
proteins because it is expressed in infected cells at a molar ratio
severalfold higher than those of the other three (C', Y1, and Y2). As
the SeV C protein was originally found abundantly in virus-infected
cells but was apparently absent in virions, it was thought to be a
nonstructural protein (22). Subsequent observations
indicated that it is detectable in small quantities in both virions and
nucleocapsids isolated from cells and virions (32, 43). The
estimated copy number of C protein in virions was as low as 40 molecules per nucleocapsid (43), indicating that SeV C
protein is not a major structural protein component. The C protein was
previously found to inhibit viral mRNA synthesis (3, 4),
probably by binding the L polymerase protein (15). The C
protein was also found to inhibit the amplification of the SeV
minigenome in cells in a promoter-specific fashion, because the
inhibitory action was exerted on an internally deleted defective interfering (DI) genome but not on a copy-back DI genome (2, 41). Thus, a presumable role of SeV C protein would be to
down-regulate both genome replication and mRNA synthesis to the levels
optimal for viral replication and/or to increase replication
selectivity toward the optimum (reviewed in reference
26).
Previously, we used reverse genetics to create mutant viruses in which
C-protein frames are silenced, in order to address the question of how
C proteins contribute to the actual viral life cycle in vitro and viral
pathogenesis in vivo. Silencing of C' and C frames, but not Y1 and Y2
expression, suggested that C proteins greatly contribute to tissue
culture replication and are indispensable for multiplication and
pathogenesis in mice. Despite such strong dependency of both in vitro
and in vivo replication on C proteins, it was possible to further
silence Y1 and Y2 frames to create a critically attenuated but still
viable clone, 4C(
) virus, in which all four C proteins were knocked
out, indicating that SeV C proteins are categorically nonessential,
accessory gene products (21). SeV was shown to suppress the
antiviral action of alpha/beta interferon (IFN-
/
) (9,
44), and this antiviral function was now attributed to the C
proteins by using various C knockout mutants (11, 12). In
this study, we attempted to further characterize the 4C(
) SeV. Our
data suggested that SeV C proteins facilitate the incorporation of
intracellular viral proteins into progeny virions. The SeV C proteins
thus appeared to play a critical role in virus assembly, although they
can be regarded as basically nonstructural proteins. This role in virus assembly was further found to be independent of anti-IFN-
/
action of the C proteins. The SeV C proteins are, therefore, quite versatile.
 |
MATERIALS AND METHODS |
Viruses.
The recovery of wild-type (WT) SeV and 4C(
) SeV
from the respective cDNA plasmids, pSeV(+) and pSeV(+)/4C(
), was
described previously (19, 21). Recovered viruses were
amplified in the allantoic cavity of 10-day-old chicken embryos, and
their titers were expressed in hemagglutination units (HAU), cell
infectious units (CIU), or PFU per milliliter as described previously
(19); 1 CIU is almost equivalent to 1 PFU. The stock virus
titers were 109 to 1010 CIU/ml for the WT SeV
and as low as about 105 CIU/ml for 4C(
) SeV.
Cell cultures and virus infection.
Monkey kidney-derived
cell lines CV1 and Vero were grown in minimal essential medium (MEM)
supplemented with 10% fetal bovine serum. Monolayer cultures of these
cells were infected with 4C(
) SeV or the WT SeV at an input
multiplicity of infection (MOI) of 5 CIU/cell unless otherwise
mentioned and maintained in serum-free MEM. At various hours
postinfection (p.i.), the culture supernatants were assayed for CIU and
HAU as previously described (20).
Northern blotting and semiquantitative RT-PCR.
Total RNA was
extracted using Trizol (Gibco BRL, Bethesda, Md.) from approximately
106 infected CV1 cells at various hours p.i. The RNAs were
ethanol precipitated, dissolved in formamide-formaldehyde solution, and then electrophoresed in a 0.9% agarose-formamide-MOPS
(morpholinepropanesulfonic acid) gel and capillary transferred onto
Hibond-N filter (Amersham Pharmacia Biotech, Uppsala, Sweden). The
filter was hybridized with a viral N gene-specific
[PstI571-RuI1760 fragment of pSeV(+)] probe,
which had been labeled with [
-32P]dCTP using
Multiprime DNA Labeling System (Amersham Pharmacia) (17).
The same filter was also hybridized with an
[
-32P]dCTP-labeled cellular glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)-specific probe. The semiquantitative reverse
transcription (RT) and PCR amplification to detect the genomic
and antigenomic RNA fragments separately were performed exactly
as described previously (17, 40) with two pairs of primers,
pHv1 (5' 1ACCAAACAAGAGAAAAAACA20 3')
and pHvNPr1 (5'
358CCATGGCAAACAGCAAGACG339 3') specific
for the leader-N region and pHvL1 (5'
14907TCTAGAAGACTTGTGCTATC14926 3') and
pHvt (5' 15384ACCAGACAAGAGTTTAAGAG15365
3') for the L-trailer region. The same RNA samples used for
Northern hybridization were reverse transcribed either with pHvL1
primer for the genomic RNA detection or with pHvNPr1 for the
antigenomic RNA detection. The reverse transcripts were then
amplified by 10, 15, and 20 cycles with the primer specific for each
genomic or antigenomic strand. PCR cycles yielding a
linear correlation between the amounts of RNA template and PCR products
were taken (17).
Antibodies.
Anti-C and anti-P sera were raised in rabbits
with the respective recombinant proteins (17). Polyclonal
anti-L serum raised in rabbits was a gift from K. Mizumoto (Kitasato
University). Mouse monoclonal antibodies against P, M, and HN were
kindly provided by A. Portner (St. Judes Research Institute), and those
against HN and H were provided by H. Taira (Iwate University). Anti-SeV rabbit polyclonal serum was described previously (19).
Western blotting.
Infected cell lysates were subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in
15% (for C proteins) or 12.5% (for others) polyacrylamide gels. The
proteins in the gels were electrotransferred onto polyvinylidene
difluoride membranes (Millipore, Bedford, Mass.) and probed with the
anti-SeV and the anti-C polyclonal antibodies as previously described
(19).
Pulse-chase experiments and immunoprecipitation.
CV1 and
Vero cells grown to subconfluency in six-well culture plates were
infected with WT or 4C(
) SeV. Infected cells maintained in serum-free
MEM for 20 h were washed three times with phosphate-buffered saline (PBS), then pulse labeled for 1 h with 20 µCi of
Tran35S protein labeling mix (ICN Biomedicals, Costa Mesa,
Calif.) per ml in cysteine- and methionine-free MEM (Nissui, Tokyo,
Japan), and then chased for 0, 1, 2, 3, and 4 h with regular MEM.
Collected supernatants at each chase point were centrifuged for 10 min
at 500 × g to remove cell debris. The clarified
supernatants were then recentrifuged at 13,000 × g for
2 h to pellet down the virions. The pellets were then resuspended
in SDS-PAGE sample buffer, boiled, and electrophoresed in SDS-12.5%
PAGE under reducing conditions. Dried gels were exposed to an image
plate, and radiolabeled proteins were visualized by using a Fujix
BAS2000 image analyzer (Fuji Photo Film, Tokyo, Japan). In addition,
CV1 cells labeled as described above for 1 h were washed
twice with PBS and lysed in 1 ml of radioimmunoprecipitation assay
(RIPA) buffer (10 mM HEPES [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1%
Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 10 µg of
aprotinin/ml) on ice, and centrifuged at 9,500 × g for 10 min to remove cell debris. Then, anti-SeV serum was added to the
supernatants of cell lysates and incubated on ice overnight. The immune
complexes generated were recovered with Protein A-Sepharose (Gibco
BRL), washed three times with RIPA buffer, and then analyzed by
SDS-12.5% PAGE as described above.
Sucrose gradient centrifugation of virions.
CV1 cells grown
to subconfluency in 175-cm2 culture bottles were infected
with either WT or 4C(
) SeV at an input MOI of 1 CIU/cell and
incubated in serum-free MEM for 16 h, washed three times with PBS,
and labeled with 20 µCi of Tran35S protein labeling mix
per ml for 24 h. The supernatants were collected and centrifuged
for 10 min at 500 × g to remove cell debris. The clarified
supernatant was then incubated with 1% ice-cold chicken red blood
cells (RBC) and kept for 30 min to allow adsorption of viral particles
onto RBC. This was followed by centrifugation at 500 × g
for 10 min and quick washing of the pellet three times with ice-cold
PBS. The pellets were then resuspended in 500 µl of PBS and incubated
at 37°C for 45 min to release the viruses from the RBC.
Virus-containing solutions (each 500 µl) were collected after
removing the RBC by centrifugation at 500 × g for 10 min and then centrifuged through 4.5 ml of 20 to
60% (vol/wt) sucrose linear gradient at 30,000 rpm for 90 min using a
Beckman SW 50 rotor. After fractionation into 20 fractions (250 µl
each), 40 µl of each fraction was electrophoresed through SDS-12.5%
PAGE gels. Autoradiographies were obtained as described above.
Immunoelectron microscopy of virions.
Volumes of 10 to 20 µl of infected CV1 culture supernatants were adsorbed on a
nickel-made mesh (Nissin EM, Tokyo, Japan). A few seconds later, excess
fluid was removed with a filter paper and blocked with 5% skim milk in
PBS for 10 min. Then, the samples were incubated with anti-SeV serum
for 10 min. After several washings with the blocking solution, samples
were incubated with anti-rabbit immunoglobulin G (IgG) labeled with
10-nm-diameter gold particles for 30 min and then washed with water
several times. The immunogold-labeled virions were stained with 2%
phosphotungstate solution (pH 7.0) for 90 s, and the excess
solution was removed with filter paper and observed under a Hitachi
H-800MU electron microscope.
Immunofluorescent microscopy.
Monolayer cultures of CV1
cells were grown on collagen-coated eight-well slide chambers (Becton
Dickinson, Franklin Lakes, N.J.) and infected with WT or 4C(
) SeV at
an input MOI of 0.5 CIU/cell and incubated in serum-free MEM for 20 and
40 h. After washing with PBS, cells were fixed with 3.7%
formaldehyde in PBS for 15 min at room temperature and then washed five
times with PBS. The fixed cells were then treated with 0.2% Triton-X
100 in PBS to permeabilize. SeV antigens were detected by incubating them with a polyclonal anti-P or anti-L rabbit serum, each at a
dilution of 1:200 in PBS or anti-HN mouse monoclonal antibody at a
dilution of 1:100 in PBS. This was followed by labeling with fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG (ICN Biomedicals) or Texas Red conjugated anti-mouse IgG (Leinco
Technologies, Inc., St. Louis, Mo.). All antibody reactions were
performed at 37°C for 45 min. Cells were washed five times with PBS
after each incubation. After mounting with an antifade reagent in
glycerol buffer (Vector Laboratories, Inc., Burlingame, Calif.), cells were observed under an epifluorescence microscope (Olympus, Tokyo, Japan). For double staining, fixed cells were incubated with rabbit anti-C polyclonal and mouse monoclonal anti-M, anti-P, or anti-HN antibody together and stained by FITC-conjugated anti-rabbit IgG and
Texas Red conjugated anti-mouse IgG. After washing and mounting as
described above, the cells were observed under an MRC-1024 confocal
laser scanning microscope (Bio-Rad, Hercules, Calif.).
Determination of cellular IFN-
/
responses.
CV1 and
Vero cells grown in six-well plates (5 × 105
cells/well) were transfected with a plasmid (pISRE-luci) containing a luciferase gene fused with an IFN-stimulated responsive element (ISRE)
(provided by K. Ozato, National Institutes of Health) at a
concentration of 1 µg/ml for 14 h. After washing with PBS, cells were treated with or without human IFN-
/
(1,000 U/ml) and
harvested at different times. Then, luciferase activity from
~104 cells was measured with a luminometer (Luminos
CT-9000D; Diaiatron, Tokyo, Japan).
 |
RESULTS |
4C(
) SeV replication in CV1 cells.
Figure
1A shows a detailed comparison of virus
replication between WT and 4C(
) SeVs in CV1 cells under single- and
multiple-cycle growth conditions with input MOIs of 5 and 0.01 CIU/cell, respectively. In single-cycle growth, 4C(
) SeV exhibited a
slower kinetics throughout the experimental period. The virus titer was
reduced by 100- to 400-fold in CIU and by 8- to 16-fold in HAU. Thus, the ratio of CIU to HAU also declined by about 10-fold in the case of
4C(
) virus infection (Fig. 1B). Under multiple-cycle growth
conditions, attenuation of 4C(
) virus was still more severe, yielding
a CIU/ml value more than 3 logs lower than that of the WT throughout
(Fig. 1A). In addition, the CIU-to-HAU ratio of 4C(
) virus at 60 h p.i. was as low as about 104, while that of the WT was
above 106 (Fig. 1B).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Replication of WT and 4C( ) viruses in CV1 cells.
(B) CIU-to-HAU ratios of the yields. (C) Immunoelectron micrographs of
CV1-grown WT and 4C( ) virions. Bar = 100 nm.
|
|
One can assume that the CIU-to-HAU ratio reflects the ratio of
infectious particles to noninfectious physical particles in
a
paramyxovirus population. Thus, the above results suggested
that 4C(

)
SeV not only replicated very poorly in CV1 cells but
also appeared to
accumulate in the culture supernatant as largely
noninfectious
particles. This prompted us to see whether morphology
would differ
between the WT and 4C(

) viruses. The virus particles
were pelleted
from the respective supernatants of infected CV1
cultures,
immunostained, and observed under an electron microscope
as described
in Materials and Methods. As expected, the WT preparation
displayed a
relatively homogenous population of spherical particles
with a diameter
of around 200 nm (Fig.
1C), which is characteristic
of SeV virions.
Typical nucleocapsid strands were also clearly
seen, and they were
enclosed with the envelope typical of SeV.
In contrast, 4C(

)
particles were highly heterogeneous, consisting
mainly of filamentous
particles (Fig.
1C). Smaller spherical particles
as well as particles
of a standard size and shape were also seen
(Fig.
1C). It has to be
noted that neither typical nucleocapsid
strands nor characteristic
envelope structures were clearly seen
for these filamentous or
spherical
particles.
As reported previously, it was remarkable that 4C(

) virus was able to
produce clear plaques, though a little smaller compared
with those of
the WT, on the same cell monolayers, suggesting
that its cell-to-cell
spreading was not greatly impaired (
21).
Viral macromolecular synthesis in CV1 cells.
Under the
single-cycle growth conditions in CV1 cells, expression of viral genes
was compared for the WT and 4C(
) viruses by Western blotting using
anti-SeV and anti-C antibodies. The data confirmed that all 4C proteins
were knocked out in the 4C(
) virus (Fig.
2A). However, the major structural
proteins P, HN, F0, and N of the 4C(
) virus were detected
with intensities comparable to those of the WT counterparts early in
infection up to 20 h p.i., and later (26 and 38 h p.i.) they
were increased. Northern blot patterns of the same infected cells with
the N-specific probe (Fig. 2B) and other viral-specific probes (not
shown) also demonstrated no appreciable suppression but increased
levels of viral transcription from 4C(
) SeV, at least late in
infection (26 and 38 h p.i.) (Fig. 2B). These findings support the
earlier notion that C proteins inhibit SeV mRNA synthesis
(4). SeV genomic RNAs are detected at the 50S
position in Northern blotting, but the aggregates of mRNAs sometimes
migrate to the same position. Thus, to measure the abundance of
genomic RNAs in infected cells, we have routinely used an
RT-PCR-based assay with specific primers (17, 40). The
results also demonstrated no impairment of genomic RNA
synthesis for 4C(
) SeV (Fig. 2C). As the assay system involved the
amplification of the far (3') ends of genome and antigenome RNAs, the
results further indicated that processivity for the 4C(
) virus was
not impaired either. In addition, the RNA levels again appeared to be
even higher for 4C(
) virus than for WT virus, at least late in
infection. It may have to be also noted that in WT infection, genomic RNA was more prominent than the anti-genomic
RNA, while in the absence of C proteins the situation was reversed
(Fig. 2C), suggesting promoter specificity of the effect of C proteins on genome replication.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
Western blotting (A) and Northern blotting (B) of CV1
cells infected with WT and 4C( ) viruses and RT-PCR-based analysis of
genome replication of the infected cells (C).
|
|
Incorporation of newly synthesized proteins into mature
virions.
In the above sections we have shown that viral gene
expression as well as the genome replication in 4C(
)-infected cells
are largely comparable to those in WT infection or even augmented, whereas the viral yield was decreased dramatically in the absence of C
proteins. These results suggested an impaired maturation or assembly of
4C(
) virion. Alternatively, mature 4C(
) virions might form normally
but be poorly released into the supernatant. Indeed, mature
paramyxovirus virions are sometimes tightly bound to the cell surface
and can only be recovered after the freezing and thawing of the cells
(28). In the case of 4C(
) infection as well as WT
infection, however, freezing and thawing of cells did not increase the
virus yields significantly (data not shown).
Then, the kinetics of viral protein incorporation into mature virions
were studied. Infected CV1 cells were labeled with Tran
35S
protein labeling mix for 1 h at 6, 14, and 20 h p.i. The
pulse
labeling patterns confirmed a level of 4C(

) viral protein
synthesis
comparable to that of the WT (Fig.
3A). The cells labeled at 20
h p.i.
were further incubated with a chase medium for 0 to 4 h,
and the
virion fractions in each culture supernatants were subjected
to
SDS-PAGE. As shown in Fig.
3B, the P and N proteins were already
detected after a 1-h chase in both WT and 4C(

) virions. In the
WT
infection, the HN and F
0 glycoproteins, as well
as the M protein,
were also detected after a 1-h chase and increased in
amount with
chase time. In sharp contrast, there was a significant
delay of
incorporation into 4C(

) virions of all three of these
proteins.
Also remarkably, relative to the amounts of P and N proteins,
the HN, F
0, and M proteins were significantly less abundant
in
the 4C(

) virions than in the WT virions (Fig.
3B). These results
strongly suggested that the C proteins somehow facilitated the
incorporation of the envelope and matrix proteins into virions
and
thereby could regulate the virus assembly.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 3.
Synthesis and incorporation into virions of viral
proteins. (A) CV1 cells infected with WT and 4C( ) viruses were pulse
labeled with Tran35S protein labeling mix for 1 h at
various hours p.i. indicated on the top of each gel lane, and the cell
lysates were processed for immunoprecipitation with anti-SeV polyclonal
antibody and SDS-PAGE. (B) At 20 h p.i., the labeled cells were
chased for the periods indicated and the virions isolated from culture
supernatants were analyzed by SDS-PAGE. The dots on the left of WT
Chase lane 1 indicate the positions of HN, F0, and M
proteins. (C) 35S-labeled WT and 4C( ) viruses were
isolated from the supernatants of infected CV1 cells by adsorption onto
and elution from chicken RBC and centrifuged through a 20 to 60%
linear gradient of sucrose. Fractionated materials were analyzed by
SDS-PAGE (t, top; b, bottom).
|
|
Highly anomalous sedimentation profile of 4C(
) virus.
We
then compared the sedimentation profiles of WT and 4C(
) virions.
After adsorbing to and elution from RBC, the virion-containing materials were centrifuged through a linear gradient of sucrose as
described in Materials and Methods. As shown in Fig. 3C, WT virions
largely sedimented into bottom fractions (fraction no. 13 to 19). In
contrast, 4C(
) particles were found to distribute throughout from the
top to bottom fractions (Fig. 3C). The amounts of viral proteins were
even greater in the top-half fractions (fraction no. 1 to 9) than in
the bottom-half fractions (fraction no. 10 to 20). These results
suggested that 4C(
) viral particles recovered from the culture
supernatant contained a fraction of particles of significantly lower
density and/or smaller sizes that were not seen in the WT preparation.
This might be relevant to highly anomalous particle structures and
sizes seen in the electron micrographs (Fig. 1C). We therefore tried
but failed to see the morphology of the top and bottom components
separately because of extremely low yields of 4C(
) virus in CV1 cells.
Immunofluorescent staining of WT- and 4C(
)-infected cells.
CV1 cells infected with WT or 4C(
) SeV were singly or doubly stained
with various antibodies presently available. When stained with anti-P
or anti-L antibody, the specific fluorescence was highly granulous in
WT infected cells (Fig. 4). These
structures were seen predominantly in the perinuclear region and could
represent inclusions formed by nucleocapsids in the natural life cycle
of SeV (32). In marked contrast, in 4C(
)-infected cells,
both viral proteins were found to distribute diffusely throughout the cytoplasm (Fig. 4). When stained with anti-HN antibody, the specific antigens distributed rather diffusely in the cytoplasm in the WT
infection and, in contrast, clearly tended to aggregate in the 4C(
)
infection (Fig. 4). Thus, SeV C proteins strongly affected the
intracellular distribution patterns of the other viral proteins, and
interestingly, its effect upon the viral internal proteins (P and L)
and upon the external protein (HN) was inverse.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 4.
Intracellular distribution of SeV proteins. CV1 cells
infected with WT and 4C( ) viruses were fixed, permeabilized, and
stained with anti-P, anti-L, and anti-HN antibodies separately at
20 h p.i. (for P and HN) or 40 h p.i. (for L).
|
|
To visualize the interaction of C proteins with the external HN
protein, internal P protein, and the M protein, double staining
and
confocal laser scanning were done for WT-infected cells. As
shown in
Fig.
5, the P proteins appeared to be
very poorly colocalized
with the C proteins. In contrast, the M and C
proteins were almost
perfectly colocalized with each other at the
perinuclear region
as well as in the entire cytoplasm. Though not as
good as this,
colocalization was also remarkable between the HN and C
proteins.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 5.
Double antibody staining of WT-infected cells with
anti-C antibody (green) and anti-P, anti-M, or anti-HN antibody (red).
Cells were fixed at 20 h p.i. Merged images in each combination
are also shown.
|
|
C-mediated effect on assembly is independent of IFN action.
Recently it was reported that C proteins of SeV were able to counteract
the antiviral action of IFN-
/
(11, 12). Thus, in the
presence of C proteins, SeV replication is refractory to exogenously
added IFN-
/
, and in their absence, viral replication is strongly
inhibited not only by the exogenously added IFN-
/
but also by
autocrine and paracrine IFN-
/
induced by the virus itself
[4C(
) virus] (12). IFN-
/
-mediated signaling is
known to involve the phosphorylation of Stat 1 molecules. This
phosphorylation was blocked in the presence of C proteins (unpublished
data). On the other hand, IFN-
/
is known to inhibit the viral
assembly or maturation at least in some virus-cell systems (33,
35, 39). Thus, the question was raised whether the defect in the assembly of 4C(
) virus was mediated by such autocrine and
paracrine IFN-
/
, if the CV1 cell line responded to IFN-
/
. A
reporter plasmid, pISRE-luci, was transfected to CV1 cells. When
treated with human IFN-
/
, the cells clearly responded, expressing
luciferase activity increasing with time after exposure to IFN-
/
(Fig. 6A, left). On the other hand,
another monkey kidney cell line, Vero, was hardly or only very poorly
able to do so (Fig. 6A, right). Thus, as previously demonstrated
(8), Vero cells were regarded as an IFN-
/
nonresponder. Then, a pulse-chase experiment was done with Vero cells
exactly as was done previously with CV1 cells (Fig. 3B) to evaluate the
kinetics of incorporation of intracellular viral proteins to the virion
fractions in the supernatants. The results indicated that the
incorporation of viral glycoproteins and matrix protein was
significantly delayed in 4C(
) infection (Fig. 6B) exactly as was seen
in CV1 cells (Fig. 3B). Therefore, this delay and probably the assembly
defect of 4C(
) virus have nothing to do with the failure to block
IFN-
/
-mediated signaling.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 6.
Response of CV1 and Vero cells to IFN- / and
incorporation of viral proteins into virions in Vero cells. (A) CV1 and
Vero cells transfected with pISRE-luci were incubated in the presence
(filled bars) or absence (open bars) of human IFN- / for the
different hours indicated and assayed for luciferase activities. (B)
Incorporation of viral proteins synthesized in infected Vero cells into
the virion fractions of the supernatants was analyzed by pulse-chase
labeling exactly as was done in Fig. 3. The dots on the left of WT
chase lane 1 indicate the positions of HN, F0, and M
proteins.
|
|
 |
DISCUSSION |
Previously, we created by reverse genetics the 4C(
) virus that
expresses none of the four C proteins and concluded that the SeV C
proteins are categorically nonessential gene products but greatly
contribute to full replication in tissue culture cells and
pathogenicity for mice (21). Here, we attempted to reveal how the C proteins would contribute to full virus replication in tissue
culture cells by comparing replication kinetics and viral
macromolecular synthesis in CV1 cells infected with the WT and 4C(
)
viruses. Under single-cycle replication conditions, 4C(
) replicated
much more slowly and to titers about 2 logs lower than those of the WT
(Fig. 1). Nevertheless, the synthesis of viral mRNAs, proteins, and
genomic RNAs was not suppressed at all or even augmented in
4C(
) infection (Fig. 2). This suggested that the assembly process was
impaired in 4C(
) infection. Indeed, when the incorporation of
intracellular viral proteins into the virion fraction of the culture
supernatants was analyzed by pulse-chase labeling, it turned out that
there was a considerable delay of incorporation of the M protein as
well as both of the envelope proteins, HN and F0 (Fig. 3B).
Additional pieces of evidence supporting the role of C proteins
in virus assembly were the anomalous sedimentation profile in the
sucrose gradient (Fig. 3C) and anomalous morphology (Fig. 1C), which
were characteristics of 4C(
) virions.
SeV C proteins counteract the antiviral action of IFN-
/
possibly
by blocking the IFN-
/
-mediated signaling and therefore play a
critical role in viral evasion of innate immunity (11, 12).
They also appear to down-regulate viral mRNA and genomic RNA
synthesis, probably in order to optimize the virus replication (2,
4, 41). The fact that 4C(
) virus displayed essentially the
same assembly defect in an IFN-
/
-nonresponding Vero cell line
(Fig. 6) clearly indicates that IFN-
/
blocking function and the
role in virus assembly of the C proteins have nothing to do with each
other. It remains to be determined whether the role in assembly and the
role in RNA synthesis are related to each other.
SeV C protein was initially regarded as a nonstructural protein
expressed in cells in large amounts and absent in virions. Although the
presence in the virions was later demonstrated, the C protein as well
as three other C-related proteins are greatly underrepresented in the
virions, compared with those in infected cells. It is, therefore,
quite unexpected that the seemingly nonstructural C proteins are
required for assembly. It is also very difficult to conceptualize how
such basically nonstructural C proteins contribute to virus assembly.
The most acceptable model of the assembly of paramyxoviruses and other
enveloped RNA viruses involves the condensation of external
glycoproteins expressed on the entire cell surface into a
patch of membrane, an immediate precursor of the envelope, by the
association of M proteins or the M and RNP complex from the inside
(29, 45). The cross-linking of SeV external
glycoproteins and internal RNP was possible only in the
presence of the M proteins (36, 46). The M proteins may
further provide force ("push") from the inside for the patch of
membranes to bud. Bending of membranes from the outside ("pull")
may be provided by glycoproteins (25, 31, 37).
It was found for influenza A virus that the interaction between the
cytoplasmic tail of neuraminidase with an internal protein (probably
the M1 protein) was necessary to drive pinching off the virions
(16). Without this interaction, the virus attained highly
irregular shape and morphology.
In the present study, we observed strict colocalization of M proteins
with the C proteins in the cytoplasm, suggesting their interaction with
each other in the natural life cycle (Fig. 5). This presumable
association, however, must be transient because the M protein is one of
the most abundant components in the virions while the C proteins are
one of the least abundant. Newly synthesized M proteins alone may be
unable to initiate virus assembly. The C protein may act as a chaperon
to convert those M proteins to an assembly-initiating form. In this
context it is worthy to note that another viral or host factor would
also be required for the assembly of the nucleocapsid-M protein complex
of vesicular stomatitis virus (10). The presumed role of SeV
C proteins in assembly also is reminiscent of the Vif protein of human
immunodeficiency virus type 1. It is also required during virus
assembly, but only the traces of this protein are present in the virion
itself (42). Alternatively, the intracellular pool of SeV M
proteins or their nascent chains may be constitutively associated with
the C protein, and only those M proteins which are then dissociated
from the C proteins may enter the assembly pathway.
Actual association between the M and C proteins remains to be
demonstrated. However, there is circumstantial evidence supporting this. The 4C(
) virus stock used here was prepared after four successive passages of the virus in eggs. We found that two additional egg passages casually resulted in generation of a virus, which displayed faster and better replication compared with that of the
fourth-passage virus but still was impaired compared with that of the
WT virus. This partial revertant possessed an M protein mutated such
that it migrated faster than that of the WT or the 4C(
) virus. This
novel phenotype of the M protein was attributed to a single point
mutation, Ala to Thr, at position 311 (unpublished data). Thus, this
point mutation in the M protein appeared to compensate at least in part
for the loss of C proteins, suggesting that the M protein can be a
target of C proteins.
Though not as strikingly as the M proteins, the HN proteins were pretty
well colocalized with the C proteins (Fig. 5). In addition, delayed
incorporation into virions was observed not only for the M protein but
also for the HN and F0 proteins (Fig. 3 and 6). Thus, it
also has to be defined whether the C proteins interact with the
envelope glycoproteins. The altered intracellular distribution of HN glycoproteins due to the absence of C
proteins (Fig. 4) may be an indirect result of the impaired virus
assembly or, alternatively, suggests the possibility of direct C-HN
interaction in the natural infection in the presence of C proteins. The
differences in intracellular distribution of the internal P and L
proteins in the presence and absence of C proteins were also striking
(Fig. 4). The formation of RNP inclusion bodies characteristic of
normal SeV infection was no longer seen in the absence of C proteins. This suggests that the C proteins may contribute to RNP formation. To
test this possibility, we isolated nucleocapsids from WT- and 4C(
)-infected cells and compared the SDS-PAGE profiles. However, no
significant differences were found; both nucleocapsids contained the N,
P, and L proteins as the major protein components in similar proportions but were poorly associated with either the M or C protein
(data not shown). Thus, the altered distribution of P and L proteins in
the absence of C proteins might be an indirect result caused by
impaired virus assembly.
As noted above, SeV C proteins are expressed as a nested set of four C
proteins. The Y1 and Y2 proteins were previously found to be unable to
fully compensate for the loss of C and C' in maintaining a normal level
of viral replication, even though Y1 and Y2 were overexpressed in the
C/C' knockout virus (21). Thus, there appear to be
functional differences at least between C-C' and Y1-Y2 groups. It
remains to be defined whether one, some, or all of the C proteins will
be required in the assembly process. The same is true for the other
functions of C proteins, such as anti-IFN-
/
action.
In summary, SeV C proteins were previously found to regulate RNA
synthesis and also appeared to be essential for the virus to counteract
the innate immunity of the host to clear the virus by IFN-
/
. It
is now clear that SeV C proteins play an essential role in virus
assembly. Thus, SeV C proteins are quite versatile. Reverse genetics
has now become available for many members of paramyxoviruses,
representing all four genera (27). Similar reverse
genetics studies of other C-protein-encoding members will greatly
facilitate the understanding of this extremely interesting and
versatile accessory gene product of members of the
Paramyxoviridae family.
 |
ACKNOWLEDGMENTS |
We thank K. Ozato, A. Portner, H. Taira, and K. Mizumoto
for providing us with pISRE-luci or SeV-specific antibodies. We also thank K. Kiyotani and S. Kuge for their technical help and suggestion.
This work was supported by research grants from the Ministry of
Education, Science, Sports and Culture, Japan, and from the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan. M.K.H. is a recipient of a BRAIN fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: AIDS Research
Center, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan. Phone: 81 3 5285-1111, ext. 2302. Fax: 81 3 5285-1165. E-mail: ynagai{at}nih.go.jp.
 |
REFERENCES |
| 1.
|
Barr, J.,
P. Chambers,
P. Harriott,
C. R. Pringle, and A. J. Easton.
1994.
Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames.
J. Virol.
68:5330-5334[Abstract/Free Full Text].
|
| 2.
|
Cadd, T.,
D. Garcin,
C. Tapparel,
M. Itoh,
M. Homma,
L. Roux,
J. Curran, and D. Kolakofsky.
1996.
The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter specific fashion.
J. Virol.
70:5067-5074[Abstract/Free Full Text].
|
| 3.
|
Curran, J.,
R. Boeck, and D. Kolakofsky.
1991.
The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing.
EMBO J.
10:3079-3085[Medline].
|
| 4.
|
Curran, J.,
J.-B. Marq, and D. Kolakofsky.
1992.
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis.
Virology
189:647-656[CrossRef][Medline].
|
| 5.
|
Curran, J., and D. Kolakofsky.
1988.
Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA.
EMBO J.
7:245-251[Medline].
|
| 6.
|
Curran, J., and D. Kolakofsky.
1989.
Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo.
EMBO J.
8:521-526[Medline].
|
| 7.
|
Curran, J., and D. Kolakofsky.
1990.
Sendai virus P gene produces multiples proteins from overlapping open reading frames.
Enzymes
44:244-249[Medline].
|
| 8.
|
Diaz, M. O.,
S. Ziemin,
M. M. Le Beau,
P. Pitha,
S. D. Smith,
R. R. Chilcote, and J. D. Rowley.
1988.
Homozygous deletion of the alpha- and beta 1 interferon genes in human leukemia and derived cell lines.
Proc. Natl. Acad. Sci. USA
85:5259-5263[Abstract/Free Full Text].
|
| 9.
|
Didcock, L.,
D. F. Young,
S. Goodbourn, and R. E. Randall.
1999.
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis.
J. Virol.
73:3125-3133[Abstract/Free Full Text].
|
| 10.
|
Flood, E. A., and D. S. Lyles.
1999.
Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus.
Virology
261:295-308[CrossRef][Medline].
|
| 11.
|
Garcin, D.,
P. Latorre, and D. Kolakofsky.
1999.
Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.
J. Virol.
73:6559-6565[Abstract/Free Full Text].
|
| 12.
|
Gotoh, B.,
K. Takeuchi,
T. Komatsu,
J. Yokoo,
Y. Kimura,
A. Kurotani,
A. Kato, and Y. Nagai.
1999.
Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon- / -mediated responses.
FEBS Lett.
459:205-210[CrossRef][Medline].
|
| 13.
|
Gupta, K. C., and S. Patwardhan.
1988.
ACG, the initiator codon for a Sendai virus protein.
J. Biol. Chem.
263:8553-8556[Abstract/Free Full Text].
|
| 14.
|
Hamaguchi, M.,
T. Yoshida,
K. Nishikawa,
H. Naruse, and Y. Nagai.
1983.
Transcriptive complex of Newcastle disease virus I. Both L and P proteins are required to constitute an active complex.
Virology
128:105-117[CrossRef][Medline].
|
| 15.
|
Horikami, S. M.,
R. E. Hector,
S. Smallwood, and S. A. Moyer.
1997.
The Sendai virus C protein binds the L polymerase protein to inhibit RNA synthesis.
Virology
235:261-270[CrossRef][Medline].
|
| 16.
|
Jin, H.,
G. P. Leser,
J. Zhang, and R. A. Lamb.
1997.
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.
EMBO J.
16:1236-1247[CrossRef][Medline].
|
| 17.
|
Kato, A.,
K. Kiyotani,
Y. Sakai,
T. Yoshida, and Y. Nagai.
1997.
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis.
EMBO J.
16:578-587[CrossRef][Medline].
|
| 18.
|
Kato, A.,
K. Kiyotani,
Y. Sakai,
T. Yoshida,
T. Shioda, and Y. Nagai.
1997.
Importance of the cysteine-rich carboxy-terminal half of V protein for Sendai virus pathogenesis.
J. Virol.
71:7266-7272[Abstract].
|
| 19.
|
Kato, A.,
Y. Sakai,
T. Shioda,
T. Kondo,
M. Nakanishi, and Y. Nagai.
1996.
Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense.
Genes Cells
1:569-579[Abstract].
|
| 20.
|
Kiyotani, K.,
S. Takao,
T. Sakaguchi, and T. Yoshida.
1990.
Immediate protection of mice from lethal wild type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity.
Virology
177:65-74[CrossRef][Medline].
|
| 21.
|
Kurotani, A.,
K. Kiyotani,
A. Kato,
T. Shioda,
Y. Sakai,
K. Mizumoto,
T. Yoshida, and Y. Nagai.
1998.
The paramyxovirus, Sendai virus, C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis.
Genes Cells
2:111-124.
|
| 22.
|
Lamb, R. A., and P. W. Choppin.
1977.
The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides.
Virology
81:371-381[CrossRef][Medline].
|
| 23.
|
Lamb, R. A., and D. Kolakofsky.
1996.
Paramyxoviridae: the viruses and their replication, p. 1177-1204.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Press, Philadelphia, Pa.
|
| 24.
|
Lamb, R. A., and R. G. Paterson.
1991.
The non-structural proteins of paramyxoviruses, p. 181-210.
In
D. W. Kingsbury (ed.), The paramyxoviruses. Plenum Press, New York, N.Y.
|
| 25.
|
Mebatsion, T.,
M. Konig, and K. K. Conzelmann.
1996.
Budding of rabies virus particles in the absence of the spike glycoprotein.
Cell
84:941-951[CrossRef][Medline].
|
| 26.
|
Nagai, Y.
1999.
Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding.
Rev. Med. Virol.
9:83-99[CrossRef][Medline].
|
| 27.
|
Nagai, Y., and A. Kato.
1999.
Paramyxovirus reverse genetics is coming of age.
Microbiol. Immunol.
43:613-624[Medline].
|
| 28.
|
Nagai, Y.,
H.-D. Klenk, and R. Rott.
1976.
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus.
Virology
72:494-508[CrossRef][Medline].
|
| 29.
|
Nagai, Y.,
H. Ogura, and H.-D. Klenk.
1976.
Studies on the assembly of Newcastle disease virus.
Virology
69:523-538[CrossRef][Medline].
|
| 30.
|
Nagai, Y.,
T. Yoshida,
M. Hamaguchi,
H. Nagura,
H. Hasegawa,
S. Yoshimura, and K. Watanabe.
1983.
Subcellular location of the major protein antigens of paramyxoviruses revealed by immunoperoxidase cytochemistry.
Microbiol. Immunol.
27:531-545[Medline].
|
| 31.
|
Peeples, M. E.
1991.
Paramyxovirus M proteins: pulling it all together and taking it on the road, 427-456.
In
D. W. Kingsbury (ed.), The paramyxoviruses Plenum Press, New York, N.Y.
|
| 32.
|
Portner, A.,
K. C. Gupta,
J. M. Seyer,
E. H. Beachey, and D. W. Kingsbury.
1986.
Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides.
Virus Res.
6:109-121[CrossRef][Medline].
|
| 33.
|
Samuel, C.
1991.
Antiviral actions of interferon: interferon regulated cellular proteins and their surprisingly selective antiviral activities.
Virology
183:1-11[CrossRef][Medline].
|
| 34.
|
Sanderson, C. M.,
H.-H. Wu, and D. P. Nayak.
1994.
Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo.
J. Virol.
68:69-76[Abstract/Free Full Text].
|
| 35.
|
Sen, G. C., and R. M. Ransohoff.
1993.
Interferon induced antiviral actions and their regulation.
Adv. Virus Res.
43:57-102.
|
| 36.
|
Shimizu, K.,
Y. K. Shimizu,
T. Kohama, and N. Ishida.
1974.
Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes.
Virology
62:90-101[CrossRef][Medline].
|
| 37.
|
Simons, K., and H. Garoff.
1980.
The budding mechanisms of enveloped animal viruses.
J. Gen. Virol.
50:1-21[Abstract/Free Full Text].
|
| 38.
|
Spiropoulou, C. F., and S. T. Nichol.
1993.
A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus.
J. Virol.
67:3103-3110[Abstract/Free Full Text].
|
| 39.
|
Staeheli, P.
1990.
Interferon induced proteins and the antiviral state.
Adv. Virus Res.
38:147-200[Medline].
|
| 40.
|
Takeda, M.,
A. Kato,
F. Kobune,
H. Sakata,
Y. Ll,
T. Shioda,
Y. Sakai,
M. Asakawa, and Y. Nagai.
1998.
Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins.
J. Virol.
72:8690-8696[Abstract/Free Full Text].
|
| 41.
|
Tapparel, C.,
S. Hausmann,
T. Pelet,
J. Curran,
D. Kolakofsky, and L. Roux.
1997.
Inhibition of Sendai virus genome replication due to promoter increased selectivity: a possible role for the accessory C proteins.
J. Virol.
71:9588-9599[Abstract].
|
| 42.
|
Trono, D.
1995.
HIV accessory proteins: leading roles for the supporting cast.
Cell
82:189-192[CrossRef][Medline].
|
| 43.
|
Yamada, H.,
S. Hayata,
T. Omata-Yamada,
H. Taira,
K. Mizumoto, and K. Iwasaki.
1990.
Association of the Sendai virus C protein with nucleocapsids.
Arch. Virol.
113:245-253[CrossRef][Medline].
|
| 44.
|
Yokoo, J.,
B. Gotoh,
T. Konmatsu,
K. Takeuchi, and T. Miyadai.
1999.
Replication-incompetent Sendai virus can suppress the antiviral action of type 1 interferon.
Arch. Virol.
144:1043-1055[CrossRef][Medline].
|
| 45.
|
Yoshida, T.,
Y. Nagai,
K. Maeno,
M. Iinuma,
M. Hamaguchi,
T. Matsumoto,
S. Nagayoshi, and M. Hoshino.
1979.
Studies on the role of M protein in virus assembly using a ts mutant of HVJ (Sendai virus).
Virology
92:139-154[CrossRef][Medline].
|
| 46.
|
Yoshida, T.,
Y. Nagai,
S. Yoshii,
K. Maeno, and T. Matsumoto.
1976.
Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly.
Virology
71:143-161[CrossRef][Medline].
|
Journal of Virology, June 2000, p. 5619-5628, Vol. 74, No. 12
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Boonyaratanakornkit, J. B., Bartlett, E. J., Amaro-Carambot, E., Collins, P. L., Murphy, B. R., Schmidt, A. C.
(2009). The C Proteins of Human Parainfluenza Virus Type 1 (HPIV1) Control the Transcription of a Broad Array of Cellular Genes That Would Otherwise Respond to HPIV1 Infection. J. Virol.
83: 1892-1910
[Abstract]
[Full Text]
-
Takeuchi, K., Komatsu, T., Kitagawa, Y., Sada, K., Gotoh, B.
(2008). Sendai Virus C Protein Plays a Role in Restricting PKR Activation by Limiting the Generation of Intracellular Double-Stranded RNA. J. Virol.
82: 10102-10110
[Abstract]
[Full Text]
-
Bartlett, E. J., Cruz, A.-M., Esker, J., Castano, A., Schomacker, H., Surman, S. R., Hennessey, M., Boonyaratanakornkit, J., Pickles, R. J., Collins, P. L., Murphy, B. R., Schmidt, A. C.
(2008). Human Parainfluenza Virus Type 1 C Proteins Are Nonessential Proteins That Inhibit the Host Interferon and Apoptotic Responses and Are Required for Efficient Replication in Nonhuman Primates. J. Virol.
82: 8965-8977
[Abstract]
[Full Text]
-
Nakatsu, Y., Takeda, M., Ohno, S., Shirogane, Y., Iwasaki, M., Yanagi, Y.
(2008). Measles Virus Circumvents the Host Interferon Response by Different Actions of the C and V Proteins. J. Virol.
82: 8296-8306
[Abstract]
[Full Text]
-
Kato, A., Kiyotani, K., Kubota, T., Yoshida, T., Tashiro, M., Nagai, Y.
(2007). Importance of the Anti-Interferon Capacity of Sendai Virus C Protein for Pathogenicity in Mice. J. Virol.
81: 3264-3271
[Abstract]
[Full Text]
-
Sakaguchi, T., Kato, A., Sugahara, F., Shimazu, Y., Inoue, M., Kiyotani, K., Nagai, Y., Yoshida, T.
(2005). AIP1/Alix Is a Binding Partner of Sendai Virus C Protein and Facilitates Virus Budding. J. Virol.
79: 8933-8941
[Abstract]
[Full Text]
-
Takeuchi, K., Takeda, M., Miyajima, N., Ami, Y., Nagata, N., Suzaki, Y., Shahnewaz, J., Kadota, S.-i., Nagata, K.
(2005). Stringent Requirement for the C Protein of Wild-Type Measles Virus for Growth both In Vitro and in Macaques. J. Virol.
79: 7838-7844
[Abstract]
[Full Text]
-
Devaux, P., Cattaneo, R.
(2004). Measles Virus Phosphoprotein Gene Products: Conformational Flexibility of the P/V Protein Amino-Terminal Domain and C Protein Infectivity Factor Function. J. Virol.
78: 11632-11640
[Abstract]
[Full Text]
-
Kato, A., Cortese-Grogan, C., Moyer, S. A., Sugahara, F., Sakaguchi, T., Kubota, T., Otsuki, N., Kohase, M., Tashiro, M., Nagai, Y.
(2004). Characterization of the Amino Acid Residues of Sendai Virus C Protein That Are Critically Involved in Its Interferon Antagonism and RNA Synthesis Down-Regulation. J. Virol.
78: 7443-7454
[Abstract]
[Full Text]
-
Mebatsion, T., de Vaan, L. T. C., de Haas, N., Romer-Oberdorfer, A., Braber, M.
(2003). Identification of a Mutation in Editing of Defective Newcastle Disease Virus Recombinants That Modulates P-Gene mRNA Editing and Restores Virus Replication and Pathogenicity in Chicken Embryos. J. Virol.
77: 9259-9265
[Abstract]
[Full Text]
-
Strahle, L., Garcin, D., Le Mercier, P., Schlaak, J. F., Kolakofsky, D.
(2003). Sendai Virus Targets Inflammatory Responses, as Well as the Interferon-Induced Antiviral State, in a Multifaceted Manner. J. Virol.
77: 7903-7913
[Abstract]
[Full Text]
-
Yokosawa, N., Yokota, S.-i., Kubota, T., Fujii, N.
(2002). C-Terminal Region of STAT-1{alpha} Is Not Necessary for Its Ubiquitination and Degradation Caused by Mumps Virus V Protein. J. Virol.
76: 12683-12690
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Kato, A., Ohnishi, Y., Hishiyama, M., Kohase, M., Saito, S., Tashiro, M., Nagai, Y.
(2002). The Amino-Terminal Half of Sendai Virus C Protein Is Not Responsible for either Counteracting the Antiviral Action of Interferons or Down-Regulating Viral RNA Synthesis. J. Virol.
76: 7114-7124
[Abstract]
[Full Text]
-
Garcin, D., Curran, J., Itoh, M., Kolakofsky, D.
(2001). Longer and Shorter Forms of Sendai Virus C Proteins Play Different Roles in Modulating the Cellular Antiviral Response. J. Virol.
75: 6800-6807
[Abstract]
[Full Text]
-
Kato, A., Ohnishi, Y., Kohase, M., Saito, S., Tashiro, M., Nagai, Y.
(2001). Y2, the Smallest of the Sendai Virus C Proteins, Is Fully Capable of both Counteracting the Antiviral Action of Interferons and Inhibiting Viral RNA Synthesis. J. Virol.
75: 3802-3810
[Abstract]
[Full Text]